EJC Supplements
Volume 5, Issue 2 , Pages 49-59 , July 2007

Treatment of invasive Candida and invasive Aspergillus infections in adult haematological patients

  • Raoul Herbrecht

      Affiliations

    • Département d’Hématologie et d’Oncologie, Hôpital de Hautepierre, 67098 Strasbourg, France
    • Corresponding Author InformationCorresponding author: Tel.: +33 388 12 76 88; fax: +33 388 12 76 81.
  • ,
  • Ursula Flückiger

      Affiliations

    • Universitätsspital Basel, Basel, Switzerland
  • ,
  • Bertrand Gachot

      Affiliations

    • Institut Gustave Roussy, Villejuif, France
  • ,
  • Patricia Ribaud

      Affiliations

    • Hôpital Saint Louis, Paris, France
  • ,
  • Anne Thiebaut

      Affiliations

    • Hôpital Edouard Herriot, Lyon, France
  • ,
  • Catherine Cordonnier

      Affiliations

    • Hôpital Henri Mondor, Créteil, France

Received 14 May 2007 ,Revised 8 June 2007 ,Accepted 11 June 2007.

  • Image Result

    Survey on current practice: preferred first line therapy for invasive candidiasis before species identification (38 responses).

    Survey on current practice: preferred first line therapy for invasive candidiasis before species identification (38 responses).

  • Image Result

    Survey on current practice: preferred therapy for invasive candidiasis after species identification (38 responses).

    Survey on current practice: preferred therapy for invasive candidiasis after species identification (38 responses).

  • Image Result

    Survey on current practice: preferred first line therapy for invasive aspergillosis (38 responses).

    Survey on current practice: preferred first line therapy for invasive aspergillosis (38 responses).

 The ECIL-1 is a common initiative of the following groups or organisations: Infectious Diseases Working Party of the European Blood and Marrow Transplantation Group (EBMT-IDWP), Infectious Diseases Group of the European Organization for Research and Treatment of Cancer (EORTC-IDG), European Leukemia Net (ELN) (EU Grant number: LSHC-CT-2004), and International Immunocompromised Host Society (ICHS).

PII: S1359-6349(07)00009-2

doi: 10.1016/j.ejcsup.2007.06.007

EJC Supplements
Volume 5, Issue 2 , Pages 49-59 , July 2007